Challenges of the Intellectual Property System in Pharmaceutical Innovations Resulting from Artificial Intelligence
The patent system has long been criticized for limiting access to medicines. Dramatic advances in artificial intelligence and machine learning technology present a revolutionary opportunity in drug discovery, formulation and testing of dosage forms. The pharmaceutical industry claims that patenting...
Saved in:
Main Authors: | Babak Sabet (Author), Shahriar Eslamitabar (Author), Ehsan Lame (Author), Fatemeh Anvar (Author) |
---|---|
Format: | Book |
Published: |
Research Center for Rational Use of Drugs (RCRUD),
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artificial Intelligence in Pharmaceuticals: Exploring Applications and Legal Challenges
by: fatemeh shaki, et al.
Published: (2024) -
Emerging of artificial intelligence and technology in pharmaceuticals: review
by: Ayesha Sultana, et al.
Published: (2023) -
Evaluation of artificial intelligence fall school program at Smart University of Medical Sciences
by: Babak Sabet, et al.
Published: (2023) -
Intellectual property rights: An overview and implications in pharmaceutical industry
by: Chandra Nath Saha, et al.
Published: (2011) -
The advancement of artificial intelligence in biomedical research and health innovation: challenges and opportunities in emerging economies
by: Renan Gonçalves Leonel da Silva
Published: (2024)